The latest Veeva Pulse Field Trends Report highlights the importance of Omnichannel Excellence in biopharma, revealing that 65% of healthcare professional (HCP) engagements remain unsynchronized. This lack of alignment leads to missed opportunities in delivering timely scientific information, despite advancements in technology. In this blog, we will summarize this report and give you the key takeaways.
The Power of Coordinated Engagement
Early adopters of a coordinated engagement model are reshaping the industry by integrating sales, marketing, medical, and service teams. This approach helps meet HCPs’ increasing demand for in-depth scientific knowledge, particularly for complex treatments. Aligning these efforts ensures that HCPs receive consistent, relevant, and timely information across multiple channels.
Data-Driven Insights for Better HCP Engagement
Data from Veeva Pulse underscores the power of omnichannel engagement. Following an in-person visit with a digital touchpoint within ten days increases the likelihood of a prescription by 30%. Similarly, HCPs exposed to digital ads after a speaker program are 25% more likely to prescribe the discussed treatment. These insights highlight the need for biopharma companies to adopt data-driven strategies that enhance engagement and drive better outcomes.
In conclusion, to succeed in today’s evolving landscape, biopharma companies must synchronize sales and marketing to deliver trusted information through HCPs’ preferred channels. A connected omnichannel strategy not only enhances engagement but also accelerates treatment adoption, ultimately benefiting patient care.
Are you looking for an omnichannel solution for Med Rep team?
Contact Trueson today for free initial consultancy. Learn more about our CRM services here.
References:
Veeva Systems. (2024). Veeva Pulse Field Trends Report. Retrieved from https://www.veeva.com/resources/veeva-pulse-field-trends-report/
